Baby girls born to mothers burdened by stress may be at risk for fibromyalgia

Autism and Pregnancy
Fibro and Pregnancy

 

Stressful or traumatic events experienced during pregnancy can have long-lasting effects on the fetus, yet these effects may not become apparent until many years later, according to a study suggesting that girls born of such pregnancies may be at greater risk for developing a painful muscle condition called fibromyalgia as adults.

The study, presented at the 6th International Congress of Neuroendocrinology (ICN 2006), shows how vulnerable a fetus is to “prenatal programming.” Indeed, animal studies presented at ICN 2006 indicate that a synthetic hormone commonly given to pregnant women at risk for delivering early can permanently affect the newborn’s neuroendocrine system and may have even more profound effects on those born in the next generation. ICN 2006 is being held at the David L. Lawrence Convention Center in Pittsburgh June 19 – 22.

Summaries of these studies’ findings follow:

Stress during pregnancy may put baby girls at later risk for fibromyalgia

New research suggests girls who were born following pregnancies that were encumbered by stressful life events may be at greater risk for developing fibromyalgia later in life. While little is known about the causes of fibromyalgia, a condition affecting mostly women and characterized by extreme fatigue and widespread muscle pain, the studies led by Dirk Hellhammer, Ph.D., professor of psychobiology at the University of Trier, Germany, indicate “prenatal programming” likely plays a role. Stress experienced during pregnancy can affect the development of the fetus’s adrenal gland, permanently limiting its capacity for producing adequate amounts of the hormone cortisol, he reports.

Compared to 100 healthy female control subjects, significantly more patients among the 93 women diagnosed with fibromyalgia reported their mothers had experienced profound stress during pregnancy, such as the loss of a partner, physical or emotional trauma or lack of social support. Moreover, of these patients born of such pregnancies, only the women had “blunted” cortisol response in a standardized measure of psychological stress, an observation that supported findings in animal studies. Furthermore, low cortisol levels were only observed in patients with a history of prenatal stress. While more study is needed, results collected so far provide strong evidence that girls may be at added risk for developing fibromyalgia if, while in the womb, they were exposed to higher than normal levels of cortisol produced by their mothers in response to stress.

Effects of steroid drug during pregnancy can span generations

A synthetic hormone commonly given to pregnant women at risk for delivering early not only can result in permanent changes to the newborn’s neuroendocrine system, but may have even greater effects on those born in the next generation, indicate results from animal studies.

Approximately 7 percent of pregnant women are treated with synthetic glucocorticoid to help hasten lung development when pre-term birth seems likely. Both animal and human clinical studies have shown the treatment could have long-term effects on neuroendocrine function and behavior. Using a guinea pig model, Stephen G. Matthews, Ph.D., professor, physiology, obstetrics & gynecology and medicine, University of Toronto, Faculty of Medicine, has shown that late-pregnancy exposure affects neurotransmitter systems – the brain’s primary communications vehicle – and makes fundamental changes to stress response mechanisms. Moreover, exposure in the womb to these synthetic hormones, which also have potent anti-inflammatory and immunosuppressive properties, can have life-long consequences. According to Dr. Matthews’ research, exposure affects the hypothalamic-pituitary-adrenal axis (HPA), which controls how the body responds to stress and is involved in regulation of energy balance and the immune system as well. Now, in more recent studies, his group is finding such effects extend to second generation offspring, in whom changes to HPA function and behavior are even greater than in those directly exposed. For instance, animals whose grandmothers were treated with glucocorticoids exhibit reduced levels of stress hormones and modified activity.

Fibromyalgia increases pain and fatigue for pregnant women

New guidelines for pregnancy in multiple sclerosis



Pregnant women with fibromyalgia (FM) experience significant pain, fatigue and psychological stress, symptoms that are often misdiagnosed or undertreated as a normal part of pregnancy, according to a pilot study by Karen M. Schaefer, D.N.Sc., R.N., assistant professor of nursing at Temple University’s College of Health Professions. Her research, the first to look at the impact of pregnancy on women with FM, was recently presented at the 2006 Association of Women’s Health, Obstetrics and Neonatal Nurses’ convention in Baltimore.Fibromyalgia is a chronic condition commonly found in women that causes pain in the muscles and soft tissues of the body. Many sufferers feel weak from fatigue, and the condition, at its worst, can lead to disability.


“Until now, there was only anecdotal evidence suggesting that women with FM had a rougher time during pregnancy,” said Schaefer. “This data is the first step toward gathering hard evidence of FM effects on this group and will hopefully help us identify ways to reduce the impact of fibromyalgia during pregnancy.”
For this study, Schaefer recruited pregnant women with and without FM through an Internet announcement on a fibromyalgia Web site. Study subjects were between the ages of 29 and 31, in their third trimester, with no history of stillbirth and free of chronic illnesses other than FM.


The women were then mailed a questionnaire about fatigue, depression, pain and ability to function. A demographic form was also used to assess the number of painful areas in the body as well as age, marital status, education, hours slept and use of medication.
Schaefer’s results revealed that the pregnant women with fibromyalgia had a hard time functioning, felt more stiff and tired, and experienced pain in more body areas than women without FM.
“Most women with FM have trouble getting this condition properly diagnosed, let alone knowing where to turn for help once their condition is identified. We need to start looking at how FM affects all areas of these women’s lives and come up with ways to provide as much comfort and support as possible,” she said.
Schaefer, whose research focuses on women with chronic illness (fibromyalgia, lupus, ovarian cancer) is currently expanding her study to include a larger group of subjects.

Fibromyalgia pain caused by neuron mismatch, suggests study

Neurons and nerve pain
Neurons and nerve pain

The unexplained pain experienced by patients with fibromyalgia is the result of a mismatch between sensory and motor systems, new research suggests.

In a study published in the journal Rheumatology, researchers asked patients to look at a reflection of one arm whilst moving their other in a different direction which was hidden behind the mirror.

This created a mismatch between what the brain sees via sensory input and what it feels through the motor system that controls movement.

Of the 29 patients involved in the study, 26 reported feeling a transient increase in pain, temperature change or heaviness in their hidden limb – all symptoms of a ‘flare up’ of their condition.

This suggests that a mismatch between sensory and motor neurons could be at the root of the fibromyalgia – a condition affecting one in 100 people in the UK at some stage of their lives.

“The chronic pain experienced by people with fibromyalgia is hard to understand because there are no obvious clinical signs that pain should be experienced,” said Dr Candy McCabe, one of the researchers involved in the University of Bath and Royal National Hospital for Rheumatic Diseases study.

“We have shown that by confusing the motor and sensory systems we can exacerbate the symptoms felt by people diagnosed with the condition.

“This adds to a growing body of evidence that many of the symptoms of this common disorder may be perpetuated, or even triggered, by this sensory-motor conflict.

“We have had some success to date in using a similar technique to help alleviate the symptoms of this kind of chronic pain.

“This works by helping the brain to see a limb moving freely without pain – although in reality it is a reflection of their pain-free limb.”

Volunteers in the study were asked to perform a series of bilateral upper and lower limb movements with a mirror in front of them at a right-angle.

This meant that one limb was obscured from view behind the mirror whilst they could clearly see the other limb and its reflection.

They first carried out the same movements with both limbs, and then made different movements.

This enabled the researchers to see what effect confusing what the brain could see with what it could feel.

“Nearly all of the group reported an increase in the sensations connected with their condition in the hidden limb,” said Dr McCabe.

“This provides strong evidence that sensory-motor conflict is at the heart of this condition.

“Some clinicians do not recognise fibromyalgia as a diagnosis because of a lack of clinical reason for the pain.

“It is often considered to be a reflection of anxiety or attention seeking behaviour which, for people with the condition, can be very hard to deal with.

“Nevertheless, fibromyalgia is one of the most common conditions seen by rheumatologists.

“Hopefully we are beginning to understand more about the condition, and taking steps towards how it might be treated in the future.”

People with fibromyalgia complain of widespread pain, multiple tender points, stiffness, sleep disturbance and fatigue.

Around nine out of ten of those affected by fibromyalgia are women. In most cases it develops between the ages of 30 and 60, but it can develop in people of any age, including children and the elderly.

There are around 14,700 new cases in the UK each year.

Anger amplifies clinical pain in women with and without fibromyalgia

Millions at risk from invisible dangers in the home this winter


Researchers from Utrecht University who studied the effect of negative emotions on pain perception in women with and without fibromyalgia found that anger and sadness amplified pain equally in both groups. Full findings are now online and will publish in the October print issue of Arthritis Care & Research, a journal of the American College of Rheumatology.

Fibromyalgia (FM), a chronic pain condition, has among the largest impact of all rheumatic and chronic pain conditions. In addition to chronic, widespread pain, patients report accompanying symptoms such as fatigue, functional disability, and psychological distress. FM is thought to involve heightened pain sensitivity to a variety of psychophysical and emotional stimuli, with negative emotions believed to be experienced more strongly in FM patients than in the general population.

The Utrecht team theorized that specific negative emotions such as sadness and anger also would increase pain more in women with FM than in healthy women. Their study examined the effects of experimentally-induced anger and sadness on self-reported clinical and experimentally-induced pain in women with and without FM. Participants consisted of 62 women with FM and 59 women without FM. Both groups were asked to recall a neutral situation, followed by recalling both an anger-inducing and a sadness-inducing situation, in counterbalanced order. The effect of these emotions on pain responses (non-induced clinical pain and experimentally-induced sensory threshold, pain threshold, and pain tolerance) was analyzed with a repeated-measures analysis of variance.

Self-reported clinical pain always preceded the experimentally-induced pain assessments and consisted of reporting current pain levels (“now, at this moment”) on a scale ranging from “no pain at all” to “intolerable pain.” Clinical pain reports were analyzed in women with FM only. Electrical pain induction was used to assess experimentally-induced pain. Participants pressed a button when they felt the current (sensory threshold) and when it became painful (pain threshold) and intolerable (pain tolerance). Four pain assessments were conducted per condition, and very high internal consistencies were obtained.

More pain was indicated by both the clinical pain reports in women with FM and pain threshold and tolerance in both groups in response to anger and sadness induction. Sadness reactivity predicted clinical pain responses. Anger reactivity predicted both clinical and electrically-stimulated pain responses.

Both women with and women without FM manifested increased pain in response to the induction of both anger and sadness, and greater emotional reactivity was associated with a greater pain response. “We found no convincing evidence for a larger pain response to anger or sadness in either study group (women with, or without FM), said study leader Henriët van Middendorp, Ph.D. “In women with FM, sensitivity was roughly the same for anger and sadness.”

Dr. van Middendorp concludes, “Emotional sensitization of pain may be especially detrimental in people who already have high pain levels. Research should test techniques to facilitate better emotion regulation, emotional awareness, experiencing, and processing.”

In a related study, a research team from Radboud University Nijmegen Medical Centre found that tailored cognitive-behavioral therapy (CBT) and exercise training tailored to pain-avoidance or pain-persistence patterns at a relatively early stage after diagnosis is likely to promote beneficial treatment outcomes for high-risk patients with FM.

The Nijmegen team evaluated the effects of this approach in a randomized controlled trial. The study compared a waiting list control condition (WLC) with patients in a treatment condition (TC) to demonstrate improvements in physical and psychological functioning and in the overall impact of FM.

High-risk patients were selected and classified into 2 groups (84 patients were assigned to a pain-avoidance group and 74 patients to the pain-persistence group) and subsequently randomized to either the TC or WLC. Treatment consisted of 16 sessions of CBT and exercise training, tailored to the patient’s specific cognitive behavioral pattern, delivered within 10 weeks. Physical and psychological functioning and impact of FM were assessed at baseline, post-treatment, and 6-month follow-up.

The treatment effects were significant, showing notable positive differences in physical (pain, fatigue, and functional disability) and psychological (negative mood and anxiety) functioning, and impact of FM for the TC in comparison with the WLC. Clinically relevant improvement was found among patients in the TC group.

“Our results demonstrate that offering high-risk FM patients a treatment tailored to their cognitive behavioral patterns at an early stage after the diagnosis is effective in improving both short-and long-term physical and psychological outcomes,” says junior investigator Saskia van Koulil. “Supporting evidence of the effectiveness of our tailored treatment was found with regard to the follow-up assessments and the low dropout rates. The effects were overall maintained at 6 months, suggesting that patients continued to benefit from the treatment.”